01 1Xellia (Taizhou) Pharmaceuticals Co. ,Ltd
02 1Xellia Pharmaceuticals AS
01 2Japanese Pharmacopoeia bacitracin
01 2Denmark
Japanese Pharmacopoeia Bacitracin
Registration Number : 225MF10193
Registrant's Address : 108 Binhai Road, Taizhou, Zhejiang 318000 PRC, China
Initial Date of Registration : 2013-10-09
Latest Date of Registration : 2013-10-09
Japanese Pharmacopoeia Bacitracin
Registration Number : 218MF10935
Registrant's Address : Harbitzalle(´)en 3, P. O. Box 158 Skφyen N-0212 Oslo, Norway
Initial Date of Registration : 2006-11-21
Latest Date of Registration : 2006-11-21
A Bacitracin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bacitracin, including repackagers and relabelers. The FDA regulates Bacitracin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bacitracin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bacitracin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bacitracin supplier is an individual or a company that provides Bacitracin active pharmaceutical ingredient (API) or Bacitracin finished formulations upon request. The Bacitracin suppliers may include Bacitracin API manufacturers, exporters, distributors and traders.
click here to find a list of Bacitracin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bacitracin Drug Master File in Japan (Bacitracin JDMF) empowers Bacitracin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bacitracin JDMF during the approval evaluation for pharmaceutical products. At the time of Bacitracin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bacitracin suppliers with JDMF on PharmaCompass.
We have 1 companies offering Bacitracin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
